News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Gastrointestinal Stromal Tumors
December 31, 2025
Qinlock (Ripretinib) for Advanced Gastrointestinal Stromal Tumors: What Patients Should Know
Charles H. Weaver, MD
December 8, 2025
GIST – Gastrointestinal Stromal Tumors: Overview
Charles H. Weaver, MD
June 20, 2021
Pimitesib Treatment for GIST
Charles H. Weaver, MD
December 1, 2020
Sarcoma Centers Provide The Best Treatment and Access to Clinical Trials
Charles H. Weaver, MD
June 9, 2020
Gleevec (Imatinib) Treatment Improves Survival in GISTs
Charles H. Weaver, MD
January 12, 2020
Ayvakit Precision Cancer Medicine Rare GIST PDGFRA Mutation
Charles H. Weaver, MD
January 19, 2019
Gastrointestinal Stromal Tumors Newsletter
Charles H. Weaver, MD
August 15, 2018
SWOG Study Shows Strong Long-Term Survival Rates for Patients with GIST
Charles H. Weaver, MD
August 1, 2018
Lutathera – Improves Outcomes for Neuroendocrine Tumors
Charles H. Weaver, MD
July 11, 2018
Stivarga Approved for Treatment of Advanced Gastrointestinal Stromal Tumors
Charles H. Weaver, MD
June 6, 2018
Surgery in Responding Patients Feasible for GIST
Charles H. Weaver, MD
June 2, 2018
Surgery for Residual GIST May Improve Outcomes
Charles H. Weaver, MD
1
2
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website